Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119(11):3189–3202

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abreu A, Tovar AP, Castellanos R, Valenzuela A, Giraldo CM, Pinedo AC et al (2016) Challenges in the diagnosis and management of acromegaly: a focus on comorbidities. Pituitary 19(4):448–457

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hannon AM, Thompson CJ, Sherlock M (2017) Diabetes in patients with acromegaly. Curr Diab Rep 17(2):8

Article  CAS  PubMed  Google Scholar 

Rodrigues TC, Costenaro F, Fedrizzi D, Oliveira MD, Lima PB, Boschi V et al (2011) Diabetes mellitus in a cohort of patients with acromegaly. Arq Bras Endocrinol Metabol 55(9):714–719

Article  PubMed  Google Scholar 

Jonas C, Maiter D, Alexopoulou O (2016) Evolution of glucose tolerance after treatment of Acromegaly: a study in 57 patients. Horm Metab Res 48(5):299–305

Article  CAS  PubMed  Google Scholar 

Fieffe S, Morange I, Petrossians P, Chanson P, Rohmer V, Cortet C et al (2011) Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. Eur J Endocrinol 164(6):877–884

Article  CAS  PubMed  Google Scholar 

Alexopoulou O, Bex M, Kamenicky P, Mvoula AB, Chanson P, Maiter D (2014) Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients. Pituitary 17(1):81–89

Article  CAS  PubMed  Google Scholar 

Clemmons DR (2002) Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary 5(3):181–183

Article  CAS  PubMed  Google Scholar 

Katznelson L, Laws ER Jr., Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951

Article  CAS  PubMed  Google Scholar 

Melmed S (2006) Medical progress: Acromegaly. N Engl J Med 355(24):2558–2573

Article  CAS  PubMed  Google Scholar 

Jaffrain-Rea ML, Minniti G, Moroni C, Esposito V, Ferretti E, Santoro A et al (2003) Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly. Eur J Endocrinol 148(2):193–201

Article  CAS  PubMed  Google Scholar 

Kinoshita Y, Fujii H, Takeshita A, Taguchi M, Miyakawa M, Oyama K et al (2011) Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic beta-cell function is preserved. Eur J Endocrinol 164(4):467–473

Article  CAS  PubMed  Google Scholar 

Tzanela M, Vassiliadi DA, Gavalas N, Szabo A, Margelou E, Valatsou A et al (2011) Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues. Clin Endocrinol (Oxf) 75(1):96–102

Article  CAS  PubMed  Google Scholar 

He W, Yan L, Wang M, Li Q, He M, Ma Z et al (2019) Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases. Endocrine 63(1):27–35

Article  CAS  PubMed  Google Scholar 

Araujo-Castro M, Biagetti B, Menendez Torre E, Novoa-Testa I, Cordido F, Pascual Corrales E et al (2024) Differences between GH and PRL co-secreting and GH-secreting pituitary adenomas. A series of 604 cases. J Clin Endocrinol Metab

Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L et al (2021) A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1):1–13

Article  PubMed  Google Scholar 

Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K et al (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85(2):526–529

CAS  PubMed  Google Scholar 

Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF et al (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141–3148

Article  CAS  PubMed  Google Scholar 

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al (2023) 2. Classification and diagnosis of diabetes: standards of Care in Diabetes-2023. Diabetes Care 46(Suppl 1):S19–S40

Article  CAS  PubMed  Google Scholar 

Riddle MC, Cefalu WT, Evans PH, Gerstein HC, Nauck MA, Oh WK et al (2021) Consensus Report: definition and interpretation of Remission in Type 2 diabetes. Diabetes Care 44(10):2438–2444

Article  CAS  PubMed  PubMed Central  Google Scholar 

Obesity (2000) Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:i–xii

Google Scholar 

Magliano DJ, Boyko EJ (2021) IDF DIABETES ATLAS. IDF Diabetes Atlas. 10th ed. Brussels

Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102–152

Article  CAS  PubMed  Google Scholar 

Li YL, Zhang S, Guo XP, Gao L, Lian W, Yao Y et al (2019) Correlation analysis between short-term insulin-like growth factor-I and glucose intolerance status after transsphenoidal adenomectomy in acromegalic patients: a large retrospective study from a single center in China. Arch Endocrinol Metab 63(2):157–166

PubMed  PubMed Central  Google Scholar 

Moller N, Jorgensen JO (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30(2):152–177

Article  PubMed  Google Scholar 

Li X, Tang J, Lin S, Liu X, Li Y (2024) Mendelian randomization analysis demonstrates the causal effects of IGF family members in diabetes. Front Med (Lausanne) 11:1332162

Article  PubMed  Google Scholar 

Sandhu MS (2005) Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology. Endocr Dev 9:44–54

Article  CAS  PubMed  Google Scholar 

Helseth R, Carlsen SM, Bollerslev J, Svartberg J, Oksnes M, Skeie S et al (2016) Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response. Endocrine 51(2):298–307

Article  CAS  PubMed  Google Scholar 

Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G et al (2006) Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab 91(1):85–92

Article  CAS  PubMed  Google Scholar 

Colao A, Auriemma RS, Galdiero M, Cappabianca P, Cavallo LM, Esposito F et al (2009) Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. J Clin Endocrinol Metab 94(2):528–537

Article  CAS  PubMed  Google Scholar 

Ronchi CL, Varca V, Beck-Peccoz P, Orsi E, Donadio F, Baccarelli A et al (2006) Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors. J Clin Endocrinol Metab 91(1):121–128

Article  CAS  PubMed  Google Scholar 

Moller N, Schmitz O, Joorgensen JO, Astrup J, Bak JF, Christensen SE et al (1992) Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab 74(5):1012–1019

CAS  PubMed  Google Scholar 

Stelmachowska-Banas M, Zielinski G, Zdunowski P, Podgorski J, Zgliczynski W (2011) The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegaly. Neurol Neurochir Pol 45(4):328–334

Article  PubMed